2018, doi: 10.1007/s00296-018-4142-x Chourpiliadis, C., et al, "Use of Common Psychiatric Medications and Risk and Prognosis of Amyotrophic Lateral Sclerosis," JAMA Network Open, June 4, 2024, doi:10.1001/jamanetworkopen.2025.14437 Meron, M.K., et al, "GLP-1 receptor agonists and the risk of fragility fractures in older adults with type 2 diabetes," Journal of Clinical Endocrinology & Metabolism, Feb.10, 2026, doi: 10.1210/clinem/dgag056 Luo, Y., et al, "GLP-1 receptor agonists in eye disease: a comprehensive review of current research and future potential," BMC Ophthalmology, Jan
The high prevalence of metabolic disorders and early adoption of novel therapeutics contribute to the regional market dominance
The CMS BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive Health) pilot program, announced in December 2025, aims to begin expanding Medicare access to obesity medications by mid-2026, with a broader Part D model rolling out in January 2027
conversely, other neighbor countries show different diagnostic rates of peptic ulcer, such as 50.9% in Malaysia and 47.6% in Thailand (Binh et al., 2018)
As Maria puts it: These drugs gave me back my health, but I had to fight for my peace of mind
3 Examples: E11.21 E11.22 + additional CKD stage code (N18.-) E11.3- (specify type: mild, moderate, severe, proliferative) E11.40E11.49 4 & add .65 (e.g., E11.65 = Type 2 with hyperglycemia) add .64 (specify with or without coma) 5 1